Structure and signifi cance of cytogenetic abnormalities in patients with multiple myeloma

T. V. Abramova; T. N. Obukhova; E. O. Gribanova; M. V. Solovev; M. V. Firsova; O. M. Votyakova; S. M. Kulikov; Yu. A. Chabaeva; I. V. Gal’tseva; L. P. Mendeleeva

Russian journal of hematology and transfusiology
Gematologiâ i transfuziologiâ

ISSN 0234-5730 (Print)
ISSN 2411-3042 (Online)

User

eng | рус

Russian journal of hematology and transfusiology

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Abramova T.V., Obukhova T.N., Gribanova E.O., Solovev M.V., Firsova M.V., Votyakova O.M., Kulikov S.M., Chabaeva Yu.A., Gal’tseva I.V., Mendeleeva L.P. Structure and signifi cance of cytogenetic abnormalities in patients with multiple myeloma. Russian journal of hematology and transfusiology. 2021;66(1):54-67. (In Russ.) https://doi.org/10.35754/0234-5730-2021-66-1-54-67

Views PDF (Rus): 800

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 0234-5730 (Print)
ISSN 2411-3042 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Elena N. Parovichnikova

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

T. V. Abramova
National Research Center for Hematology
Russian Federation

Tatiana V. Abramova, Cand. Sci. (Med.), Physician, Laboratory of Karyology

125167, Moscow

T. N. Obukhova
National Research Center for Hematology
Russian Federation

Tatiana N. Obukhova, Cand. Sci. (Med.), Head of the Laboratory of Karyology

125167, Moscow

E. O. Gribanova
National Research Center for Hematology
Russian Federation

Elena O. Gribanova, Cand. Sci. (Med.), Head of the Department of Intensive High-Dose Chemotherapy for Hematological Diseases with round-the-clock and day hospitals

125167, Moscow

M. V. Solovev
National Research Center for Hematology
Russian Federation

Maxim V. Solovev, Cand. Sci. (Med.), Head of the Department of Intensive High-Dose Chemotherapy for Paraproteinemic Hemoblastosis

125167, Moscow

M. V. Firsova
National Research Center for Hematology
Russian Federation

Maiia V. Firsova, Cand. Sci. (Med.), Senior Researcher, Department of Intensive High-Dose Chemotherapy for Paraproteinemic Hemoblastosis

125167, Moscow

O. M. Votyakova
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation

Olga M. Votyakova, Cand. Sci. (Med.), Senior Researcher, Department of Chemotherapy for Hemoblastosis

115478, Moscow

S. M. Kulikov
National Research Center for Hematology
Russian Federation

Sergey M. Kulikov, Cand. Sci. (Tech.), Head of the Information and Analytical Department

125167, Moscow

Yu. A. Chabaeva
National Research Center for Hematology
Russian Federation

Yulia A. Chabaeva, Cand. Sci. (Tech.), Senior Researcher, Information and Analytical Department

125167, Moscow

I. V. Gal’tseva
National Research Center for Hematology
Russian Federation

Irina V. Gal’tseva, Cand. Sci. (Med.), Head of the Laboratory of Blood and Bone Marrow Immunophenotyping

125167, Moscow

L. P. Mendeleeva
National Research Center for Hematology
Russian Federation

Larisa P. Mendeleeva, Dr. Sci. (Med.), Professor, Director of the Science and Education Office, Head of the Department of Chemotherapy for Paraproteinemic Hemoblastosis

125167, Moscow

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Russian journal of hematology and transfusiology

For citations:

Cookies policy